Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitonin Mesotherapy vs Peri-articular Prolotherapy in Knee Osteoarthritis
IRCT20241219064100N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of TBRIA in knee osteoarthritis (OA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pain reduction and Functional improvement. Started Feb 2025; status: completed.
02
Drugs
TBRIA
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20241219064100N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241219064100N1.